RESUMO
Three impurities in ropinirole hydrochloride drug substance at levels approximately 0.06-0.15% were detected by reverse-phase high performance liquid chromatography (HPLC). These impurities were isolated from the drug substance. These impurities were analyzed using reverse-phase HPLC. Based on the spectral data (IR, NMR and MS), structures of these impurities were characterized as 4-[2-(propylamino) ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride (impurity-A), 5-[2-(diropylamino) ethyl]-1,4-dihydro-3H-benzoxazin-3-one hydrochloride (impurity-B) and 4-[2-(diropylamino) ethyl]-1H-indol-2,3-dione hydrochloride (impurity-C). Synthesis of these impurities is discussed.
Assuntos
Antiparkinsonianos/análise , Indóis/análise , Antiparkinsonianos/química , Cromatografia Líquida de Alta Pressão/métodos , Contaminação de Medicamentos , Indóis/química , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Estrutura Molecular , Espectrofotometria Infravermelho , Espectroscopia de Infravermelho com Transformada de FourierRESUMO
The equilibrium problems, characterized by recurring end-points, involved in the reaction of iron (III) with iodide make the batch iodometric determination of iron (III) unsuitable. Since the flow injection determination does not require attainment of steady state either for mixing of reagents or for the chemical reaction, the iodometric determination has been accurately and precisely performed using this technique in the present work. This method does not require any special reagent, including chelating agents or those which are loxic, and has a limit of detection of 0.2 micromol l(-1) (11 microg l(-1)) of iron (III). The interference of fluoride has been avoided by adding zirconyl nitrate to the test sample solution, and of copper (II) by complex formation with 2-mercaptobenzoxazole. The method has been applied to determine iron (III) in natural waters, and total iron in drugs.
